Designer vaccine nanodiscs for personalized cancer immunotherapy. - Wikidata - awgldk - TriplyDB

Designer vaccine nanodiscs for personalized cancer immunotherapy.

Designer vaccine nanodiscs for personalized cancer immunotherapy.

http://www.wikidata.org/entity/Q37730767

about

Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting.Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.Combinatorial drug delivery approaches for immunomodulation.Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.Multi-epitope vaccines: a promising strategy against tumors and viral infections.Engineering biodegradable guanidyl-decorated PEG-PCL nanoparticles as robust exogenous activators of DCs and antigen cross-presentation.A STING-activating nanovaccine for cancer immunotherapy.Synthetic nanovaccines for immunotherapy.Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma.Rethinking cancer nanotheranostics.Computer-Aided Design of an Epitope-Based Vaccine against Epstein-Barr Virus.Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy.Toward Personalized Peptide-Based Cancer Nanovaccines: A Facile and Versatile Synthetic Approach.Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy.Exploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination.Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy.Novel Identified HLA-A*0201-Restricted Hantaan Virus Glycoprotein Cytotoxic T-Cell Epitopes Could Effectively Induce Protective Responses in HLA-A2.1/Kb Transgenic Mice May Associate with the Severity of Hemorrhagic Fever with Renal Syndrome.Improving Vaccine and Immunotherapy Design Using Biomaterials.Surface-Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy.Towards personalized, tumour-specific, therapeutic vaccines for cancer.Deep Tumor Penetrating Bioparticulates Inspired Burst Intracelluar Drug Release for Precision Chemo-Phototherapy.High-density lipoprotein-mimicking nanodiscs carrying peptide for enhanced therapeutic angiogenesis in diabetic hindlimb ischemia.Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.Integration of nano drug-delivery system with cancer immunotherapy.Nanomaterials for cancer immunotherapy.Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment.A bifunctional nanomodulator for boosting CpG-mediated cancer immunotherapy.A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors.Subcutaneous Nanodisc Vaccination with Neoantigens for Combination Cancer Immunotherapy.Nanodelivery of a functional membrane receptor to manipulate cellular phenotype.Extra-Large Pore Mesoporous Silica Nanoparticles Enabling Co-Delivery of High Amounts of Protein Antigen and Toll-like Receptor 9 Agonist for Enhanced Cancer Vaccine Efficacy.The perfect personalized cancer therapy: cancer vaccines against neoantigens.Elimination of established tumors with nanodisc-based combination chemoimmunotherapy.Reconstituted high-density lipoproteins: novel biomimetic nanocarriers for drug delivery.Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy Structural effects and lymphocyte activation properties of self-assembled polysaccharide nanogels for effective antigen delivery PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy The swinging pendulum of cancer immunotherapy personalization

P2860

Q38403588-F8DC105A-4989-4949-A8E1-4FAFF4696A42 Q38677432-C8C7D5F0-7C88-4A8A-80FD-DE00BF61D3BE Q38680602-16E084D7-956A-4503-ABBD-87E9145AF97D Q40044791-624DEDD7-EC53-4BB2-9463-ED3E1EED7739 Q40048585-FB2F14BB-171F-4237-99C8-F83C960691A3 Q40065038-7E08C007-FCDB-4561-BA05-3E7504CF27EA Q40230470-A34AA20A-ADDD-4CDE-971A-4DD05B74CEE3 Q40280801-BC3364F8-93AD-48A5-B7DC-6AC744769781 Q41355414-694A121B-D1C2-4078-A509-A91358F2B1FF Q42640884-B98FBBE1-4FDA-4B38-AD5A-753029FB6206 Q44549769-C3921616-1305-40A3-B49A-56DB9807AC4D Q46205951-7013CAE4-9B5F-4BF4-94EF-717951415148 Q46429495-55D0CC6E-93D8-49B0-899E-45426C012147 Q47146257-169B00E2-9CDD-4BDB-A169-0A3058F93FF1 Q47201342-7EA4310F-9085-41DD-AE62-7C71D8456047 Q47342244-CA789D6F-6420-46E6-8311-E5C85C28F026 Q47556915-2F7E5E0E-7818-43FD-9B04-A54B09D0D2C2 Q47676665-48C4A93A-61E9-4D45-A1E5-BEC7B90722B1 Q47730058-463027C7-7F50-443D-944E-04E166CD5A13 Q47789519-40B0830B-F3CD-4208-ABE6-6B94B7F8A816 Q48269486-1375474F-B945-4F52-BEE5-2CA7AAC7757F Q48505813-57E0B4B3-8530-4352-8E82-D2013A8AB1A3 Q48526348-518701FC-C368-4A06-8C10-D2A21437B57E Q48622958-47CA5F12-18DC-4FB8-AF2D-2F19B7D21D6F Q48646732-ED548291-6431-48E8-811C-490F078CFF31 Q49391681-133D2DE4-33D1-4EC9-96E7-EE2FD274DA18 Q50072990-41AB8C5B-9956-47AA-B12F-D81933950E4F Q52579555-1D4CA80E-44EF-4178-8AE1-58DFF78C093F Q52683235-AF7A9381-BC1D-4E3C-99EF-277FB57E4D1C Q52687677-E91B8AE1-4C3A-4B22-9BC8-CC531E0FE1D4 Q54940414-216896C5-D898-47B0-811D-72E51A87FF99 Q55001351-E4FD15E6-B106-4A5E-A383-29CE066C5C01 Q55044963-EE600AB5-F02A-407A-8282-A76A1D385C3A Q55350285-47FB3B13-E1EF-4051-883B-6DB8CB1016D6 Q56993652-0CD7C746-B2CE-477A-AEFC-6DE11B6F95B4 Q57177418-0230E6C7-1D7A-41A6-9277-5EF3F9F35A8A Q58602700-EC220C46-B5BB-4C41-A999-6D54C89FF57F Q58792025-EF75A2CA-315A-4E6E-8DD9-F3E761FF0F56 Q58924840-BF88BDBE-6D26-4160-A767-BA72CAE0F037

P2860

Designer vaccine nanodiscs for personalized cancer immunotherapy.

http://www.wikidata.org/entity/Q37730767

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Designer vaccine nanodiscs for personalized cancer immunotherapy.

@en

Designer vaccine nanodiscs for personalized cancer immunotherapy.

@nl

type

label

Designer vaccine nanodiscs for personalized cancer immunotherapy.

@en

Designer vaccine nanodiscs for personalized cancer immunotherapy.

@nl

prefLabel

Designer vaccine nanodiscs for personalized cancer immunotherapy.

@en

Designer vaccine nanodiscs for personalized cancer immunotherapy.

@nl

P1433

Q37730767-DCD52FE5-E248-4F1E-A905-5E7DD62D1491

P1476

Q37730767-F63C3777-6C5D-4F7E-AFAD-2BEC2715FC82

P2093

Q37730767-040DE089-5894-4124-8251-67873D530B28

Q37730767-36CD1DBC-DD2D-404C-B206-29AFADE565EC

Q37730767-60F8588B-B468-4219-9999-3FF2EA6C64F9

Q37730767-8D432829-321F-4B38-8877-59BC226B8C3F

Q37730767-C5089D41-262C-4CEA-8FFE-F686F64BE335

P2860

Q37730767-0A148D95-4601-492F-83C9-46336003A918

Q37730767-14F17F2F-1728-4EB5-9BFC-0EC413E202FE

Q37730767-1A35DC5A-1570-4F05-9701-213770D73442

Q37730767-1A3924BA-628B-47B7-949A-017238AC9AD6

Q37730767-222E3C9A-F8B7-445B-8D04-DA093E7F1642

Q37730767-236EFE7B-9773-4655-819F-E63D0F908D07

Q37730767-27532D1B-9938-4309-8CA0-F8CFBF290F80

Q37730767-2B1A1C4C-9146-496D-9F03-EA5B14852D86

Q37730767-2D6A9689-5587-41CA-8ED2-126AE0EC6BF7

Q37730767-2DB68773-F652-4E61-AEC7-6AD71406E325

P2888

Q37730767-2B668EF8-2F1F-41BA-9D54-A270612D1F97

P304

Q37730767-40ABA3B8-AA96-4D9B-8DE2-7771059E0DD2

P31

Q37730767-3E44B4FD-703D-47A7-B01E-6C5F2FF89150

P356

Q37730767-CE818858-7132-468D-AC3E-C72C6143F46C

P407

Q37730767-4E6F355E-7EE4-402D-9F8D-54D0F2707A5B

P433

Q37730767-6D72E31A-EAF2-455E-B140-335143862699

P478

Q37730767-2E82BB6E-8A5A-4B94-A3FF-4C5F85D0B86A

P577

Q37730767-FFB44FED-DB3A-44DA-B266-E47CE5FB2AB7

P698

Q37730767-A32E516A-CA33-4456-9F60-3104DDE56648

P921

Q37730767-0895AF5D-70A3-49E0-B97A-59E18A584072

P932

Q37730767-78435200-1795-4E90-8367-5D9D0634A3D2

P356

P1433

Nature Materials

P1476

Designer vaccine nanodiscs for personalized cancer immunotherapy.

@en

P2093

Anna Schwendeman

http://www.w3.org/2001/XMLSchema#string

James J Moon

http://www.w3.org/2001/XMLSchema#string

Keith S Bahjat

http://www.w3.org/2001/XMLSchema#string

Lukasz J Ochyl

http://www.w3.org/2001/XMLSchema#string

Rui Kuai

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy

Combining radiotherapy and cancer immunotherapy: a paradigm shift

Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

High-Density Lipoproteins: Nature's Multifunctional Nanoparticles

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.

P2888

P304

489-496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NMAT4822

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28024156

http://www.w3.org/2001/XMLSchema#string

P921

P932

5374005

http://www.w3.org/2001/XMLSchema#string